(Q46452581)

22 December 2017

title

Letter regarding 'Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate'. (English)

1 reference

22 December 2017

author name string

Michael D L Smyth

series ordinal

1

1 reference

22 December 2017

Raymond D Pratt

series ordinal

2

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

22 December 2017

published in

Kidney International

1 reference

22 December 2017

volume

74

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

536; author reply 536-7

1 reference

22 December 2017

Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.170

7 January 2021

Nephrogenic systemic fibrosis, gadolinium, and iron mobilization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.170

7 January 2021

Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.170

7 January 2021

Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of gadolinium deposits in skin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.170

7 January 2021

Absolute bioavailability and disposition of lanthanum in healthy human subjects administered lanthanum carbonate.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.170

7 January 2021

Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.170

7 January 2021

Identifiers

DOI

10.1038/KI.2008.170

1 reference

22 December 2017

1 reference

22 December 2017